Natixis Advisors, L.P. Illumina, Inc. Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Illumina, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 371,611 shares of ILMN stock, worth $50.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

371,611

Previous 372,979 0.37%

Holding current value

$50.6 Million

Previous $38.9 Million 24.48%

% of portfolio

0.09%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$105.28 - $135.9 $144,023 - $185,911	-1,368 Reduced 0.37%	371,611 $48.5 Million
Q2 2024 Aug 01, 2024	SELL	$101.05 - $133.57 $1.51 Million - $1.99 Million	-14,907 Reduced 3.84%	372,979 $38.9 Million
Q1 2024 Apr 25, 2024	BUY	$127.73 - $147.2 $9.41 Million - $10.8 Million	73,642 Added 23.43%	387,886 $53.3 Million
Q4 2023 Feb 06, 2024	BUY	$92.79 - $142.53 $1.72 Million - $2.65 Million	18,569 Added 6.28%	314,244 $43.8 Million
Q3 2023 Nov 13, 2023	SELL	$128.91 - $192.44 $5.9 Million - $8.81 Million	-45,801 Reduced 13.41%	295,675 $40.6 Million
Q2 2023 Aug 15, 2023	BUY	$183.43 - $232.67 $2.91 Million - $3.69 Million	15,845 Added 4.87%	341,476 $64 Million
Q1 2023 May 11, 2023	BUY	$193.75 - $232.55 $8.83 Million - $10.6 Million	45,586 Added 16.28%	325,631 $75.7 Million
Q4 2022 Jan 27, 2023	BUY	$187.24 - $242.74 $790,527 - $1.02 Million	4,222 Added 1.53%	280,045 $56.6 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $1.94 Million - $2.48 Million	10,924 Added 4.12%	275,823 $52.6 Million
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $2.27 Million - $4.61 Million	12,522 Added 4.96%	264,899 $48.8 Million
Q1 2022 May 12, 2022	SELL	$303.87 - $423.8 $621,110 - $866,247	-2,044 Reduced 0.8%	252,377 $88.2 Million
Q4 2021 Feb 08, 2022	SELL	$347.28 - $421.83 $17.8 Million - $21.6 Million	-51,114 Reduced 16.73%	254,421 $96.8 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $50.2 Million - $64.9 Million	123,654 Added 67.99%	305,535 $124 Million
Q2 2021 Aug 12, 2021	SELL	$372.84 - $481.5 $317,286 - $409,756	-851 Reduced 0.47%	181,881 $86.1 Million
Q1 2021 May 05, 2021	BUY	$361.28 - $504.76 $1.06 Million - $1.48 Million	2,935 Added 1.63%	182,732 $70.2 Million
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $468,320 - $593,536	-1,600 Reduced 0.88%	179,797 $66.5 Million
Q3 2020 Nov 12, 2020	BUY	$268.51 - $400.74 $8.34 Million - $12.4 Million	31,054 Added 20.66%	181,397 $56.1 Million
Q2 2020 Aug 11, 2020	BUY	$256.46 - $373.01 $18.4 Million - $26.8 Million	71,853 Added 91.54%	150,343 $55.7 Million
Q1 2020 Apr 27, 2020	BUY	$209.2 - $335.53 $11.2 Million - $17.9 Million	53,487 Added 213.92%	78,490 $21.4 Million
Q4 2019 Feb 10, 2020	BUY	$288.29 - $335.49 $1.32 Million - $1.53 Million	4,574 Added 22.39%	25,003 $8.29 Million
Q3 2019 Nov 12, 2019	SELL	$266.84 - $378.23 $222,544 - $315,443	-834 Reduced 3.92%	20,429 $6.22 Million
Q2 2019 Aug 12, 2019	BUY	$300.59 - $368.15 $1.04 Million - $1.27 Million	3,445 Added 19.33%	21,263 $7.83 Million
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $578,938 - $682,186	2,124 Added 13.53%	17,818 $5.54 Million
Q4 2018 Feb 13, 2019	BUY	$272.46 - $366.54 $993,116 - $1.34 Million	3,645 Added 30.25%	15,694 $4.71 Million
Q3 2018 Nov 13, 2018	BUY	$279.04 - $367.06 $138,124 - $181,694	495 Added 4.28%	12,049 $4.42 Million
Q2 2018 Aug 14, 2018	SELL	$228.17 - $292.07 $75,980 - $97,259	-333 Reduced 2.8%	11,554 $0
Q1 2018 May 10, 2018	BUY	$209.54 - $253.91 $315,148 - $381,880	1,504 Added 14.49%	11,887 $2.81 Million
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $2.1 Million - $2.39 Million	10,383	10,383 $2.27 Million

Others Institutions Holding ILMN

# of Institutions

908

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Illumina, Inc. Transaction History